Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalytic Reduction . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101062897B details a novel Al-Ni alloy reduction for 2,3-dihydro-1H-inden-1-amine. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Novel 4-step synthesis from dimethyl isophthalate offers high yield and purity for electronic component coatings, reducing purification complexity.
Novel patent CN117362269A enables high-purity alpha-lipoic acid intermediate production with stable processes and reduced hazardous chemical usage for supply chain reliability.
Advanced Raney Nickel reduction process for high-purity iopromide intermediates. Cost-effective, atmospheric pressure synthesis suitable for commercial scale-up.
Patent CN101880242B details a green Raney Nickel catalytic hydrogenation route for 3-amino-4-methoxyacetanilide, offering high purity and reduced environmental impact for dye manufacturers.
Patent CN104846025A details enzymatic synthesis of chiral intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103923020A reveals a cost-effective synthesis route for Ticagrelor intermediates. Enhance supply chain reliability and reduce manufacturing costs with optimized chemistry.
Patent CN107794282B reveals a high-yield biocatalytic route for Crizotinib intermediates using Geotrichum candidum, offering superior purity and cost efficiency for API manufacturing.
Patent CN104130194A reveals a green catalytic hydrogenation route for 5-Amino-2-benzimidazolinone, offering superior purity and supply chain reliability for pharmaceutical manufacturers.
Patent CN102925500A enables high-purity chiral ester synthesis via yeast biocatalysis, offering cost-effective and scalable pharmaceutical intermediate solutions for global supply chains.
Discover a novel diethylene glycol route for synthesizing 4-(4-aminophenyl)morpholine-3-one. This eco-friendly, high-yield process offers significant cost reduction in API manufacturing.
Patent CN104232696A reveals biocatalytic method for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106380409A reveals a cost-effective asymmetric reduction route for Levalbuterol. Enhance supply chain reliability with scalable, high-purity pharmaceutical intermediate production capabilities.
Patent CN104177394B reveals a cost-effective Entecavir intermediate route with mild conditions, offering supply chain stability and high purity for antiviral drug production.
Patent CN105985990B details a green enzymatic route for phenylephrine intermediates using KRED and antioxidants, offering significant cost reduction in API manufacturing.
Patent CN114751807B reveals a novel low-cost route for 2 3 5 6 tetrafluorobenzyl alcohol ensuring high purity and supply chain stability for global agrochemical manufacturers.
Patent CN112176019B details a high-yield biocatalytic route for (R)-1-(3-trifluoromethylphenyl) ethanol using recombinant E. coli and deep eutectic solvents, ensuring >99.9% e.e. and scalable production for neuroprotective intermediates.
Patent CN102206170A details a mild, one-pot synthesis of Agomelatine using Nickel Chloride, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN105087664A reveals high-yield biocatalytic route for chiral intermediates ensuring supply chain stability and significant cost efficiency for global pharmaceutical manufacturing partners seeking reliable production.
Patent CN106520856A enables high-concentration enzymatic reduction for pharmaceutical intermediates. Achieve superior purity and scalable supply chain reliability.